Role of the mitochondrial permeability transition in salicylate toxicity to cultured rat hepatocytes: Implications for the pathogenesis of Reye's syndrome

被引:77
作者
Trost, LC [1 ]
Lemasters, JJ
机构
[1] Univ N Carolina, Dept Cell Biol & Anat, Chapel Hill, NC 27599 USA
[2] Univ N Carolina, Sch Med, Curriculum Toxicol, Chapel Hill, NC 27599 USA
关键词
aspirin; acetylsalicylic acid; salicylate; valproic acid; neem oil; Margosa oil; hypoglycin; 4-methylvaline cyclosporin; cyclosporin A; mitochondrial permeability transition; Reye's syndrome; Jamaican Vomiting Sickness; hepatotoxicity; urea cycle disorders; disorders of fatty acid oxidation;
D O I
10.1006/taap.1997.8313
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Aspirin is strongly implicated in the pathogenesis of Reye's syndrome, a childhood disorder characterized by hyperammonemia, microvesicular steatosis, and encephalopathy. Previously, we showed that salicylate, the active metabolite of aspirin, induces the mitochondrial permeability transition (MPT) in isolated mito-chondria, as do several other chemicals implicated in Reye's-related disorders. Opening of a high conductance, cyclosporin A-sensitive pore in the mitochondrial inner membrane causes the MPT, leading to swelling, depolarization, and uncoupling of oxidative phosphorylation. The goal of this study was to characterize the role of the MPT in salicylate toxicity to cultured rat hepatocytes. Salicylate (0.3-5 mM) caused concentration-dependent cell killing. In Krebs-Ringer buffer, half-maximal cell killing occurred 150 min after 3 mM salicylate. Increasing Ca2+ enhanced salicylate lethality. Salicylate-dependent cell killing was blocked by 0.5-5 mu M cyclosporin A and its nonimmunosuppresive analog, 4-methylvaline cyclosporin, implicating the MPT in the pathogenesis of cell killing. The contribution of the MPT to lethal cell injury was confirmed by laser scanning confocal microscopy, which demonstrated the redistribution of the fluorophore calcein from the cytosol into mitochondria prior to cell killing, an event blocked by cyclosporin A. Salicylate toxicity was enhanced at high extracellular Ca2+. In the range of 10-100 mu M, several chemically diverse calcium antagonists blocked or reduced salicylate toxicity including verapamil, diltiazem, chlorpromazine, nifedipine, and nisoldipine. Calcium antagonists also blocked the increase of mitochondrial free Ca2+ in high Ca2+ buffer, as determined by confocal imaging of the fluorophore Rhod-2. These data with salicylate suggest that onset of the MPT may be the common pathophysiologic mechanism causing mitochondrial injury in Reye's syndrome and Reye's-reiated drug toxicities. Further, elevated intramitochondrial Ca2+ may be a predisposing condition promoting onset of the MPT by Reye's-related chemicals. (C) 1997 Academic Press.
引用
收藏
页码:431 / 441
页数:11
相关论文
共 69 条
[1]  
Bacq Y, 1993, Gastroenterologist, V1, P257
[2]   Protection in the late stages of paracetamol-induced liver cell injury with fructose, cyclosporin A and trifluoperazine [J].
Beales, D ;
McLean, AEM .
TOXICOLOGY, 1996, 107 (03) :201-208
[3]   RECENT PROGRESS ON REGULATION OF THE MITOCHONDRIAL PERMEABILITY TRANSITION PORE - A CYCLOSPORINE-SENSITIVE PORE IN THE INNER MITOCHONDRIAL-MEMBRANE [J].
BERNARDI, P ;
BROEKEMEIER, KM ;
PFEIFFER, DR .
JOURNAL OF BIOENERGETICS AND BIOMEMBRANES, 1994, 26 (05) :509-517
[4]  
BERNARDI P, 1992, J BIOL CHEM, V267, P2934
[5]   THE ALTERATIONS IN THE ENERGY-LINKED PROPERTIES INDUCED IN RAT-LIVER MITOCHONDRIA BY ACETYLSALYCILATE ARE PREVENTED BY CYCLOSPORINE-A OR MG2+ [J].
BIBAN, C ;
TASSANI, V ;
TONINELLO, A ;
SILIPRANDI, D ;
SILIPRANDI, N .
BIOCHEMICAL PHARMACOLOGY, 1995, 50 (04) :497-500
[6]   CYCLOSPORINE-A PROTECTS HEPATOCYTES SUBJECTED TO HIGH CA-2+ AND OXIDATIVE STRESS [J].
BROEKEMEIER, KM ;
CARPENTERDEYO, L ;
REED, DJ ;
PFEIFFER, DR .
FEBS LETTERS, 1992, 304 (2-3) :192-194
[7]  
BROEKEMEIER KM, 1989, J BIOL CHEM, V264, P7826
[8]   Inhibition of the mitochondrial permeability transition by cyclosporin a during long time frame experiments: Relationship between pore opening and the activity of mitochondrial phospholipases [J].
Broekemeier, KM ;
Pfeiffer, DR .
BIOCHEMISTRY, 1995, 34 (50) :16440-16449
[9]   THE BIOCHEMISTRY OF REYES-SYNDROME [J].
BROWN, RE ;
FORMAN, DT .
CRC CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES, 1982, 17 (03) :247-297
[10]  
CASTEELSVANDAELE M, 1991, EUR J PEDIATR, V150, P456